BioSpace News Archive

BlueWind Medical Announces the Publication of Breakthrough Results for BLUEWIND-RENOVA Implantable Tibial Nerve Neuromodulator

The scientific publication was published in the September issue of the Neuromodulation and Urodynamics journal.

January 4, 2018
·
3 min read
Drug Development

Neuraltus Pharma Announces Completion of Last Patient Visit in Confirmatory Phase II Study of NP001 for the Treatment of Amyotrophic Lateral Sclerosis

The study was conducted to confirm previous Phase 2 findings in ALS patients with elevated levels of systemic inflammation.

January 4, 2018
·
3 min read
Drug Development

Eiger BioPharma Completes Enrollment of Phase II ULTRA Study of Ubenimex in Primary and Secondary Lymphedema Patients

ULTRA is a randomized, placebo-controlled study designed to evaluate the effects of ubenimex in patients with primary and secondary lymphedema of the lower limb(s).

January 4, 2018
·
5 min read
Business

Servier and Treventis Begin Strategic Research Partnership in Neurodegenerative Diseases

This therapeutic strategy aims to provide patients with a drug that slows the progression of pathology in the brain, thereby minimizing functional decline through a disease-modifying mechanism.

January 4, 2018
·
4 min read
Biotech Beach

Biocept Obtains Patent in Australia for its Molecular Biomarker Technology For the Detection of Cancer-Associated Mutations in Blood, Tissue, and Other Biological Sources

This is the second issued patent for Biocept’s Target Selector assays for molecular analysis using real-time PCR, Sanger sequencing and NGS.

January 4, 2018
·
5 min read
Genetown

ImmusanT Provides Year-End Update and Outlines Goals for 2018

ImmusanT today provided an update on accomplishments from 2017 and outlined goals for 2018.

January 4, 2018
·
5 min read
Drug Development

Cortexyme Initiates Phase I Clinical Development of COR388, a Promising Potential Treatment for Alzheimer’s and Other Degenerative Diseases

Cortexyme today announced the first cohort has been dosed in the initial trial of its phase 1 clinical development program for COR388, the company’s lead compound.

January 4, 2018
·
3 min read
Acasti Expands Global Patent Portfolio with Newly Granted Patents in South Korea and Canada

Acasti today announced the granting of a patent by the South Korean Patent Office and the granting of a corresponding patent by the Canadian Intellectual Property Office, further strengthening the international intellectual property position of CaPre.

January 4, 2018
·
4 min read
BioMidwest

Abbott Gains Ground as Revolutionary Continuous Glucose Monitoring System Wins Medicare Coverage

The system is the only CGM system recognized by Medicare that requires no user calibration whatsoever.

January 4, 2018
·
7 min read
Drug Development

Rhythm Pharmaceuticals Announces Progress in Clinical Development of Setmelanotide for Treatment of Rare Genetic Disorders of Obesity

Final protocol confirmed for pivotal Phase 3 clinical trial in pro-opiomelanocortin (POMC) deficiency obesity,

January 4, 2018
·
7 min read